PEGFILGRASTIM AS PROPHYLAXIS OF FEBRILE NEUTROPENIA DURING CHEMOTHERAPY OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Cerchione, C. [1 ]
Pugliese, N. [1 ]
Marano, L. [1 ]
Cerciello, G. [1 ]
Avilia, S. [1 ]
Pane, F. [1 ]
Catalano, L. [1 ]
机构：
[1] AOU Federico II, Hematol, Naples, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1030
引用
收藏
页码：424 / 424
页数：1
相关论文
共 50 条
  • [31] Therapy of relapsed and relapsed refractory multiple myeloma
    Driessen, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 113 - 113
  • [32] Management of Relapsed and Relapsed/Refractory Multiple Myeloma
    Laubach, Jacob P.
    Mitsiades, Constantine S.
    Mahindra, Anuj
    Luskin, Marlise R.
    Rosenblatt, Jacalyn
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Avigan, David
    Raje, Noopur
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Richardson, Paul G.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (10): : 1209 - 1216
  • [33] Clinical synergism of Bortezomib and chemotherapy in relapsed and refractory multiple myeloma.
    Mazumder, A
    Chauvin, E
    Curran, K
    Disperati, P
    Jagannath, S
    BLOOD, 2003, 102 (11) : 390B - 390B
  • [34] Risk factors for refractory febrile neutropenia in urological chemotherapy
    Yasufuku, Tomihiko
    Shigemura, Katsumi
    Tanaka, Kazushi
    Arakawa, Soichi
    Miyake, Hideaki
    Fujisawa, Masato
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (02) : 211 - 216
  • [35] Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors
    Lambertini, Matteo
    Ferreira, Arlindo R.
    Del Mastro, Lucia
    Danesi, Romano
    Pronzato, Paolo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1799 - 1817
  • [36] Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia
    Aarts, Maureen J.
    Grutters, Janneke P.
    Peters, Frank P.
    Mandigers, Caroline M.
    Dercksen, M. Wouter
    Stouthard, Jacqueline M.
    Nortier, Hans J.
    van Laarhoven, Hanneke W.
    van Warmerdam, Laurence J.
    van de Wouw, Agnes J.
    Jacobs, Esther M.
    Mattijssen, Vera
    van der Rijt, Carin C.
    Smilde, Tineke J.
    van der Velden, Annette W.
    Temizkan, Mehmet
    Batman, Erdogan
    Muller, Erik W.
    van Gastel, Saskia M.
    Joore, Manuela A.
    Borm, George F.
    Tjan-Heijnen, Vivianne C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4283 - 4289
  • [37] Teclistamab in Relapsed or Refractory Multiple Myeloma
    Moreau, Philippe
    Garfall, Alfred L.
    van de Donk, Niels W. C. J.
    Nahi, Hareth
    San-Miguel, Jesus F.
    Oriol, Albert
    Nooka, Ajay K.
    Martin, Thomas
    Rosinol, Laura
    Chari, Ajai
    Karlin, Lionel
    Benboubker, Lotfi
    Mateos, Maria-Victoria
    Bahlis, Nizar
    Popat, Rakesh
    Besemer, Britta
    Martinez-Lopez, Joaquin
    Sidana, Surbhi
    Delforge, Michel
    Pei, Lixia
    Trancucci, Danielle
    Verona, Raluca
    Girgis, Suzette
    Lin, Shun X. W.
    Olyslager, Yunsi
    Jaffe, Mindy
    Uhlar, Clarissa
    Stephenson, Tara
    Van Rampelbergh, Rian
    Banerjee, Arnob
    Goldberg, Jenna D.
    Kobos, Rachel
    Krishnan, Amrita
    Usmani, Saad Z.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 495 - 505
  • [38] APPROACH IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Delforge, Michel
    LEUKEMIA RESEARCH, 2014, 38 : S14 - S14
  • [39] The Management of Relapsed and Refractory Multiple Myeloma
    Gahvari, Zhubin J.
    Callander, Natalie S.
    ONCOLOGY-NEW YORK, 2023, 37 (04): : 164 - 174
  • [40] Treatment of relapsed or refractory multiple myeloma
    Maiolino, Angelo
    Garnica, Marcia
    LEUKEMIA RESEARCH, 2018, 73 : S3 - S3
12345